药物对比
Erenumab vs Fremanezumab
比较用于偏头痛预防的CGRP单克隆抗体Erenumab（Aimovig）与Fremanezumab（Ajovy）。受体靶向与配体靶向、每月与每季度给药、疗效和安全性。
此页面暂无可用的对比维度。
临床背景
Patients and clinicians selecting a CGRP monoclonal antibody for preventive treatment of episodic or chronic migraine.
结论
Both agents provide similar migraine-prevention efficacy; choice is driven by dosing schedule and tolerability rather than overall superiority.
全部药物对比